Circle Pharma, Inc.
Macrocyclic small-molecule therapeutics for cancer and serious diseases
- Sector
- Biotech
- Headquarters
- SOUTH SAN FRANCISCO, CA
- Founded
- 2012
- Latest Form D
- $54.2M, Jul 2024
- Total capital
- $109M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $109M
- 4 Form D · last Jul 2024
- 28 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 14 pending · first 2022
- Rank in peer group#481 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$54.2M
- Private capital raisedForm D · SEC · 3rd filing$35.7M
- Private capital raisedForm D · SEC · 2nd filing$15M
- Private capital raisedForm D · SEC · 1st filing$3.8M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#481 · top 33%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Cayla J. McEwenExecutive OfficerNamed in SEC Form D filings
- David EarpExecutive Officer, DirectorNamed in SEC Form D filings
- Douglas R. CrawfordDirectorNamed in SEC Form D filings
- Elton J. SatuskyExecutive OfficerNamed in SEC Form D filings
- James H. EvangelistaDirectorNamed in SEC Form D filings
- John JoseyDirectorNamed in SEC Form D filings
Show all 13 people
- Matthew P. JacobsonDirectorNamed in SEC Form D filings
- Paul H. ParkExecutive OfficerNamed in SEC Form D filings
- Peter SvennilsonDirectorNamed in SEC Form D filings
- Scott R. LokeyDirectorNamed in SEC Form D filings
- Stephen H. KelseyDirectorNamed in SEC Form D filings
- Thilo H. SchroederDirectorNamed in SEC Form D filings
- Walter P. MoosDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 15- PendingCyclin InhibitorsUSPTOApplication 18667080
- PendingCyclin InhibitorsUSPTOApplication 18491380
- GrantedCyclative Release Of Peptidic CompoundsUSPTOUS 11,299,513
Show all 15 patent records
- Cyclin InhibitorsDec 12, 2024 · Application 18667080Pending
- Cyclin InhibitorsJul 4, 2024 · Application 18491380Pending
- Cyclative Release Of Peptidic CompoundsApr 12, 2022 · US 11,299,513Granted
- Cyclin InhibitorsApplication 63637984Pending
- Cyclin InhibitorsApplication 63637995Pending
- Cyclin InhibitorsApplication 63638000Pending
- Cyclin InhibitorsApplication 63612533Pending
- Cyclin InhibitorsApplication PCTUS2023077448Pending
- Cyclin InhibitorsApplication 63467651Pending
- Cyclin InhibitorsApplication 63380562Pending
- Cyclative Release Of Peptidic CompoundsApplication PCTUS2018044182Pending
- Cyclin InhibitorsApplication PCTUS2025026047Pending
- Cyclative Release Of Peptidic CompoundsApplication 62538477Pending
- Cyclin InhibitorsApplication PCTUS2025026045Pending
- Cyclin InhibitorsApplication PCTUS2024029839Pending
Related companies, and why
- Aeovian PharmaceuticalsSimilar federal contract value in Biotech · null in contracts
- ILiAD BiotechnologiesSimilar federal contract value in Biotech · null in contracts
- Acrivon Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- BigHat Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
- Entact Bio, Inc.Similar federal contract value in Biotech · null in contracts
- CIRC Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .